Exploring Opportunities: Flow Cytometry Market Projections By 2022 to 2032

The global flow cytometry industry size is gearing up for unprecedented growth, marking a transformative journey from a valuation of US$ 5.6 Billion in 2022 to an anticipated US$ 11.4 Billion by 2032. This trajectory, fueled by a Compound Annual Growth Rate (CAGR) of 7.4%, showcases a burgeoning landscape within the industry, as outlined in the latest report by Future Market Insights.

One of the key revelations of the report is the dominance of reagents, consumables & accessories, spearheading the market with a substantial 44.3% share in 2021, solidifying its stronghold in the global market. This trend underscores the integral role these products play in shaping and steering the flow cytometry sector towards exponential growth.

Request A Sample Copy Of This Research Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-5263

In biology and medicine, the flow cytometry market is a powerful tool for analysing and quantifying a wide range of properties of individual cells in a diverse population. It allows scientists to investigate the size, complexity, form, and expression of specific chemicals inside or outside of cells, among other cellular properties.

The flow cytometry process makes use of a flow cytometer, a specialised piece of equipment that can analyse thousands of cells per second. The cells are first labelled with fluorescent markers that bind precisely to the target molecules. As the cells pass through the flow cytometer in a single file, laser beams illuminate the fluorescent markers, causing them to release light signals that are detected by detectors. These signals are then converted into measurable information that provides in-depth information on every single cell.

According to projections from Future Market Insights, reagents, consumables, and accessories will command the flow cytometry market by product in 2021, accounting for around 44.3% of the global market. Global flow cytometry is projected to play a bigger role in medicine as a result of developments in in vivo flow cytometry, high-throughput quantitative analysis, and assessments of minimal residual diseases.

Key Takeaways:

• A rising number of immunoassay techniques are rapidly being developed including the Accuri flow cytometer attributed to the recombinant antibody technology. Recombinant antibodies are extensively being used during the development of more sophisticated panels that come with affordable flow cytometer prices.
• By combining the high specificity and affinity of monoclonal antibodies with recombinant technology, monoclonal antibodies incorporate a stronger ability to detect subtle antigenic alterations and small targets comprising epitope variants, post-translational modifications, and conformational changes.
• Furthermore, nowadays it has become very common to change the flow cytometry region in order to avoid clashes with several other antibodies within a flow cytometry panel. By decreasing the high background which commonly takes place when antibodies bind to Fc receptors, recombinant antibodies have reduced the flow cytometry cost. As a result, varieties of market opportunities are now being established by the introduction of recombinant DNA technology for antibody production in flow cytometry.
• The development of monoclonal antibodies, fluorescence, and laser technology has managed to diversify by adding new options for developing the best flow cytometers to investigate intracellular compartments for the determination of cellular functionality. In addition to that, the expansion of business over digital distribution channels has proven to be groundbreaking development for several small flow cytometer manufacturers with a limited and dispersed customer base.

Competitive Landscape:

Due to the presence of local and regional businesses, the overall market is highly fragmented and several significant companies in the manufacture of flow cytometry are experiencing intense competition. The leading competitors in the flow cytometry market are employing strategies like acquisitions and mergers, collaborations and partnerships, and new product launches in order to increase the consumer base and satisfy consumer expectations.

Key Players Profiled in the Flow Cytometry Market Report:

• Beckman Coulter, Inc. (Danaher)
• Becton Dickinson & Co.
• Life Technologies Corporation (Thermo Fisher Scientific Inc.)
• Miltenyi Biotech
• Luminex Corp.
• Merck KGaA
• bioMérieux SA
• Agilent Technologies
• Bio-Rad Laboratories
• Apogee Flow Systems Ltd.

More Insights into the Flow Cytometry Market:

The U.S., which held a total market share of around 92.0% in 2021 and is likely to continue seeing the same growth during the forecast period, is expected to dominate the North American flow cytometry market.

China, which held a 42.1% market share in 2021 and is anticipated to develop at a lucrative CAGR of 12.3% over the course of the forecast period, is the second-largest nation controlling the East Asian flow cytometry market.

Key Segments:

By Product Type:

• Flow Cytometer System
  • Tradition Flow Cytometer
    • Cell Sorters
    • Imaging Flow Cytometers
  • Acoustic Focusing Cytometers
  • Next Generation Flow Cytometers
  • Reagents, Consumables & Accessories
  • Software
  • Services

By Application:

• Immunophenotyping
• Cell Sorting
• Cell Cycle Analysis
  • Apoptosis
  • Cell Proliferation Assays
  • Intracellular Calcium Flux
• Detection & Sorting of Exosomes
• Others

By Usage:

• Research Use
• Clinical Diagnostics

By End User:

• Hospitals
• Diagnostic Laboratories
• Academic and Research Institute
• Biopharmaceutical Companies